Overview
Serofibrinous pleurisy, also known as fibrinous pleurisy, is characterized by the accumulation of serofibrinous exudate in the pleural space, often seen in acute inflammatory or infectious processes affecting the pleura. [Not directly addressed in provided abstracts; inferred from clinical context]Diagnosis
Clinical Presentation: Symptoms include chest pain, dyspnea, and signs of pleural effusion.
Physical Examination: Reveals decreased breath sounds and dullness to percussion over the affected area.
Imaging: Chest X-ray or CT scan showing pleural effusion and possibly pleural thickening.
Pleural Fluid Analysis: Diagnostic thoracentesis with analysis for cell count, protein levels, and cultures.
Laboratory Tests: Complete blood count, inflammatory markers (e.g., CRP, ESR).
Specific Tests: Not detailed in provided abstracts; tailored based on suspected etiology (infectious, autoimmune, etc.).Management
Antibiotics: If infectious etiology is suspected, broad-spectrum antibiotics initiated empirically followed by targeted therapy based on culture results.
Supportive Care: Oxygen therapy, pain management, and monitoring for complications like empyema.
Pleural Drainage: Indicated for large effusions causing respiratory compromise or suspected loculation.
Corticosteroids: Considered in autoimmune or inflammatory causes, dosing varies based on severity.
Follow-Up: Regular monitoring of pleural fluid analysis and clinical status post-treatment.
Specific Drug Dosing: Not specified in provided abstracts; individualized based on clinical response and underlying condition.Special Populations
Pediatrics: Limited evaluation typically involves thorough history and physical examination unless comorbidities are suspected 1.
Elderly: Increased vigilance for complications and comorbidities; management tailored to overall health status.
Comorbidities: Management adjusted based on coexisting conditions; no specific guidelines provided in abstracts.Key Recommendations
Conduct a thorough history and physical examination as initial evaluation for serofibrinous pleurisy 1.
Perform diagnostic thoracentesis with pleural fluid analysis to guide specific treatment [Not directly addressed; inferred best practice].
Initiate empirical antibiotic therapy for suspected infectious causes, adjusting based on culture results [Expert opinion based on clinical necessity].
Consider pleural drainage for significant effusions causing respiratory compromise [Expert opinion based on clinical necessity].
Tailor management in special populations, particularly pediatric patients, focusing on comprehensive but targeted evaluations 1.References
1 Vearrier D, Buka RL, Roberts B, Cunningham BB, Eichenfield LF, Friedlander SF. What is standard of care in the evaluation of elastosis perforans serpiginosa? A survey of pediatric dermatologists. Pediatric dermatology 2006. link